Improving Insomnia in Patients With Opioid Use Disorder
- Conditions
- InsomniaOpioid Use Disorder
- Interventions
- Behavioral: Sleep HygieneBehavioral: Mindfulness
- Registration Number
- NCT05588726
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
This randomized, 35-day research study (n=20) explores the effects of a simplified mindfulness intervention in opioid use disorder patients stabilized on buprenorphine maintenance therapy (BMT), aiming to alleviate insomnia, monitor BMT dose, and decrease non-prescribed opioid use. Patients tap along with their breathing at bedtime and practice sleep hygiene; controls do sleep hygiene only. Adherence will be monitored by a smartphone application.
- Detailed Description
This research study is exploring the effects of a simplified mindfulness intervention in patients with opioid use disorder who are stabilized on buprenorphine maintenance therapy. This study aims to improve their sleep quality, monitor changes in buprenorphine dose, and decrease the frequency of non-prescribed opioids use. We will be enrolling a total of 20 patients who are above 18 years of age and have insomnia symptoms, opioid use disorder, and access to a smartphone. Patients will be asked to utilize a smartphone application which will allow us to monitor adherence; they will be asked to tap on the screen in time with their breathing before bedtime. Buprenorphine maintenance therapy is used to treat opioid use disorder (the buprenorphine will be prescribed by their healthcare provider as part of their standard clinical care and is not a research study intervention) by minimizing withdrawal symptoms, but symptoms of insomnia often persist. Symptoms of insomnia include difficulty falling/staying asleep, anxiety regarding sleep, or daytime sleepiness.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Age greater than 18
- Diagnosed with Opioid Use Disorder
- Stable on Buprenorphine Maintenance Therapy for at least 4 weeks
- At least 3 nights of greater than 30 minutes of sleep onset latency
- Speak English above 6th grade level
- Access to smart device
- Inability to communicate verbally
- Involved in another insomnia study
- Medical or other factors that in the opinion of the study research team would interfere with their ability to participate in the intervention
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mindfulness Sleep Hygiene - Mindfulness Mindfulness - Sleep Hygiene Sleep Hygiene -
- Primary Outcome Measures
Name Time Method Sleep Onset Latency Day 28 Time to fall asleep as derived from the Sleep Diary
- Secondary Outcome Measures
Name Time Method Daytime Cravings Days 1 through 14 Smartphone app usage during the day
Non-Prescribed Opioid Use Days -1, 7, 14, and 28 Non-Prescribed Opioid Use Questionnaire
Trial Locations
- Locations (1)
Perelman School of Medicine, University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States